401 related articles for article (PubMed ID: 16904088)
1. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.
Rui T; Feng Q; Lei M; Peng T; Zhang J; Xu M; Abel ED; Xenocostas A; Kvietys PR
Cardiovasc Res; 2005 Feb; 65(3):719-27. PubMed ID: 15664399
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
8. Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms.
Liang F; Gao E; Tao L; Liu H; Qu Y; Christopher TA; Lopez BL; Ma XL
Cardiovasc Res; 2004 Jun; 62(3):568-77. PubMed ID: 15158149
[TBL] [Abstract][Full Text] [Related]
9. North American ginseng protects the heart from ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase.
Wu Y; Lu X; Xiang FL; Lui EM; Feng Q
Pharmacol Res; 2011 Sep; 64(3):195-202. PubMed ID: 21621617
[TBL] [Abstract][Full Text] [Related]
10. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.
Frantz S; Adamek A; Fraccarollo D; Tillmanns J; Widder JD; Dienesch C; Schäfer A; Podolskaya A; Held M; Ruetten H; Ertl G; Bauersachs J
Basic Res Cardiol; 2009 Nov; 104(6):773-9. PubMed ID: 19548059
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury.
Elrod JW; Greer JJ; Bryan NS; Langston W; Szot JF; Gebregzlabher H; Janssens S; Feelisch M; Lefer DJ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1517-23. PubMed ID: 16645153
[TBL] [Abstract][Full Text] [Related]
13. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
14. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
16. Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation.
Li J; Zhang H; Wu F; Nan Y; Ma H; Guo W; Wang H; Ren J; Das UN; Gao F
Crit Care Med; 2008 May; 36(5):1551-8. PubMed ID: 18434880
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.
Urao N; Okigaki M; Yamada H; Aadachi Y; Matsuno K; Matsui A; Matsunaga S; Tateishi K; Nomura T; Takahashi T; Tatsumi T; Matsubara H
Circ Res; 2006 Jun; 98(11):1405-13. PubMed ID: 16645141
[TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin inhibits angiotensin II induced cardiomyocyte hypertrophy in vitro via activating PI3K/Akt-eNOS pathway].
Wen Y; Ma YX; Zhang XJ; Hong LF; Feng DY; Lu ZH
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):436-40. PubMed ID: 19781221
[TBL] [Abstract][Full Text] [Related]
19. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model.
Hannan RL; John MC; Kouretas PC; Hack BD; Matherne GP; Laubach VE
J Surg Res; 2000 Sep; 93(1):127-32. PubMed ID: 10945953
[TBL] [Abstract][Full Text] [Related]
20. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
Martin SR; Emanuel K; Sears CE; Zhang YH; Casadei B
Cardiovasc Res; 2006 Apr; 70(1):97-106. PubMed ID: 16545353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
